Skip to main navigation Skip to search Skip to main content

Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain

  • Chad E. Bennett
  • , Duane A. Burnett
  • , William J. Greenlee
  • , Chad E. Knutson
  • , Peter Korakas
  • , Cheng Li
  • , Deen Tulshian
  • , Wen Lian Wu
  • , Rosalia Bertorelli
  • , Silva Fredduzzi
  • , Mariagrazia Grilli
  • , Gianluca Lozza
  • , Angelo Reggiani
  • , Alessio Veltri

Research output: Contribution to journalArticlepeer-review

Abstract

A series of fused tricyclic mGluR1 antagonists containing a pyridone ring were synthesized. In vitro, these antagonists were potent against both human and rat isozymes, as well as selective for inhibiting mGluR1 over mGluR5. When dosed orally, several examples were active in vivo in a rat SNL test.

Original languageEnglish
Pages (from-to)1575-1578
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume22
Issue number4
DOIs
Publication statusPublished - 15 Feb 2012
Externally publishedYes

Keywords

  • Fused tricyclic pyridones
  • GPCR
  • MGluR1 (metabotropic glutamate receptor 1)
  • Neuropathic pain
  • Spinal nerve ligation (SNL)

Fingerprint

Dive into the research topics of 'Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain'. Together they form a unique fingerprint.

Cite this